Chronic Multimorbidity Patterns in Relation to COVID-19 Severe Infection
Mrisk-COVID
Risk of Severe COVID-19, Taking Into Account Multimorbidity Patterns, as Well as Other Clinical and Sociodemographic Variables. Big Data Mrisk-COVID Project
1 other identifier
observational
14,286
1 country
1
Brief Summary
The aim of the study was to analyze the patterns of chronic multimorbidity of a cohort of Covid-19 patients, and to assess the relation between the patterns and the development of severe infection or mortality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2021
CompletedFirst Submitted
Initial submission to the registry
July 27, 2021
CompletedFirst Posted
Study publicly available on registry
July 28, 2021
CompletedAugust 4, 2021
July 1, 2021
1 month
July 27, 2021
July 28, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Covid-19 severe infection
Severe COVID-19 infection was defined as the occurrence of at least one of the following conditions during any of the registered COVID-19 episodes: severe respiratory affection (including insufficiency, failure, or distress); use of respiratory support (including mechanical ventilation or oxygen therapy); septic shock; multiple organ failure (the combination of respiratory failure and any other organ failure); inflammatory response; admission to intensive care unit; and mortality.
From 27-February-2020 to 15-June-2020
Covid-19 mortality
Death associated to COVID-19 infection episode
From 27-February-2020 to 15-June-2020
Eligibility Criteria
Confirmed or suspected Covid-19 patients from the first wave of the pandemic, aged \>20 years, residing in a healthcare region of about 400.000 inhabitants in a Northeast region of Spain (Vallès Occidental Est, Catalonia, Spain).
You may qualify if:
- Positive results of Covid-19 laboratory tests
- Covid-19 related clinical profile verified by healthcare professionals
You may not qualify if:
- Male \>90 years
- Females \>95 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Corporacion Parc Taulilead
- Agència de Qualitat i Avaluació Sanitàriescollaborator
- Instituto Aragones de Ciencias de la Saludcollaborator
Study Sites (1)
Corporacio Parc Taulí
Sabadell, 08208, Spain
Related Publications (1)
Lleal M, Corral-Vazquez C, Bare M, Comet R, Herranz S, Baigorri F, Gimeno-Miguel A, Raurich M, Fortia C, Navarro M, Poblador-Plou B, Bare M. Multimorbidity patterns in COVID-19 patients and their relationship with infection severity: MRisk-COVID study. PLoS One. 2023 Aug 31;18(8):e0290969. doi: 10.1371/journal.pone.0290969. eCollection 2023.
PMID: 37651465DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Coordinator
Study Record Dates
First Submitted
July 27, 2021
First Posted
July 28, 2021
Study Start
January 1, 2021
Primary Completion
January 31, 2021
Study Completion
May 31, 2021
Last Updated
August 4, 2021
Record last verified: 2021-07